⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OTLK News
Outlook Therapeutics, Inc. Common Stock
Outlook Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
globenewswire.com
OTLK
Outlook Therapeutics Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
globenewswire.com
OTLK
Outlook Therapeutics Re-Submits Biologics License Application for ONS-5010
globenewswire.com
OTLK
Outlook Therapeutics Provides Update on Type A Meeting with FDA
globenewswire.com
OTLK